Loading clinical trials...
Loading clinical trials...
The purpose of this study is to determine the safety and efficacy of VEC-162 compared to placebo to improve sleep parameters in a model of insomnia.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Vanda Pharmaceuticals
NCT05780177 · Posttraumatic Stress Disorder, Insomnia Disorder
NCT06373718 · Insomnia, Depression
NCT05393830 · Sleep, Insomnia, and more
NCT07384429 · Parkinson's Disease, Insomnia, and more
NCT06032377 · Insomnia
Vanda Investigational Site
Birmingham, Alabama
Vanda Investigational Site
Phoenix, Arizona
Vanda Investigational Site
San Diego, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions